Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
Tóm tắt
Engaging the endocannabinoid system through inhibition of monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), degrading endocannabinoids (endoCBs) 2-arachidonoylglycerol (2-AG) and anandamide (AEA), was proposed as a promising approach to ameliorate migraine pain. However, the activity of MAGL and FAAH and action of endoCB on spiking activity of meningeal afferents, from which migraine pain originates, has not been explored thus far. Therefore, we here explored the analgesic effects of endoCB enhancement in rat and human meningeal tissues. Both MAGL and FAAH activity and local 2-AG and AEA levels were measured by activity-based protein profiling (ABPP) and LC–MS/MS, respectively, in rat meninges obtained from hemiskulls of P38-P40 Wistar rats and human meninges from elderly patients undergoing non-migraine related neurosurgery. The action on endoCBs upon administration of novel dual MAGL/FAAH inhibitor AKU-005 on meningeal afferents excitability was tested by investigating paired KCl-induced spiking and validation with local (co-)application of either AEA or 2-AG. Finally, the specific TRPV1 agonist capsaicin and blocker capsazepine were tested. The basal level of 2-AG exceeded that of AEA in rat and human meninges. KCl-induced depolarization doubled the level of AEA. AKU-005 slightly increased spontaneous spiking activity whereas the dual MAGL/FAAH inhibitor significantly decreased excitation of nerve fibres induced by KCl. Similar inhibitory effects on meningeal afferents were observed with local applications of 2-AG or AEA. The action of AKU-005 was reversed by CB1 antagonist AM-251, implying CB1 receptor involvement in the anti-nociceptive effect. The inhibitory action of AEA was also reversed by AM-251, but not with the TRPV1 antagonist capsazepine. Data cluster analysis revealed that both AKU-005 and AEA largely increased long-term depression-like meningeal spiking activity upon paired KCl-induced spiking. In the meninges, high anti-nociceptive 2-AG levels can tonically counteract meningeal signalling, whereas AEA can be engaged on demand by local depolarization. AEA-mediated anti-nociceptive effects through CB1 receptors have therapeutic potential. Together with previously detected MAGL activity in trigeminal ganglia, dual MAGL/FAAH inhibitor AKU-005 appears promising as migraine treatment.
Tài liệu tham khảo
Messlinger K (2009) Migraine: where and how does the pain originate? Exp brain Res 196:179–193. https://doi.org/10.1007/s00221-009-1756-y
Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8:679–690. https://doi.org/10.1016/S1474-4422(09)70090-0
Bolay H, Vuralli D, Goadsby PJ (2019) Aura and Head pain: relationship and gaps in the translational models. J Headache Pain 20:94. https://doi.org/10.1186/s10194-019-1042-8
Messlinger K (2018) The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system. J Headache Pain 19:22. https://doi.org/10.1186/s10194-018-0848-0
Messlinger K, Balcziak LK, Russo AF (2020) Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators. J Neural Transm 127:431–444. https://doi.org/10.1007/s00702-020-02161-7
Edvinsson L, Grell A-S, Warfvinge K (2020) Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion. J Mol Neurosci 70:930–944. https://doi.org/10.1007/s12031-020-01493-z
Edvinsson L, Chan KY, Eftekhari S et al (2010) Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia 30:1233–1240. https://doi.org/10.1177/0333102410362122
Christiansen IM, Edvinsson JCA, Reducha PV et al (2022) Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release. J Headache Pain 23:30. https://doi.org/10.1186/s10194-022-01399-8
Maione S, Bisogno T, de Novellis V et al (2006) Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 re. J Pharmacol Exp Ther 316:969–982. https://doi.org/10.1124/jpet.105.093286
Lichtman AH, Martin BR (1991) Spinal and supraspinal components of cannabinoid-induced antinociception. J Pharmacol Exp Ther 258:517–523
Jaggar SI, Hasnie FS, Sellaturay S, Rice AS (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189–199. https://doi.org/10.1016/S0304-3959(98)00041-4
Farquhar-Smith WP, Rice ASC (2001) Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated with Inflammation of the Urinary Bladder. Anesthesiology 94:507–513. https://doi.org/10.1097/00000542-200103000-00023
Matsuda LA, Lolait SJ, Brownstein MJ et al (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564. https://doi.org/10.1038/346561a0
Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65. https://doi.org/10.1038/365061a0
Mechoulam R, Ben-Shabat S, Hanus L et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83–90. https://doi.org/10.1016/0006-2952(95)00109-d
Starowicz K, Makuch W, Osikowicz M et al (2012) Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms. Neuropharmacology 62:1746–1755. https://doi.org/10.1016/j.neuropharm.2011.11.021
Leimuranta P, Khiroug L, Giniatullin R (2018) Emerging role of (endo)cannabinoids in migraine. Front Pharmacol 9:1–7. https://doi.org/10.3389/fphar.2018.00420
Tassorelli C, Greco R, Silberstein SD (2019) The endocannabinoid system in migraine: from bench to pharmacy and back. Curr Opin Neurol 32:405–412. https://doi.org/10.1097/WCO.0000000000000688
Aaltonen N, Savinainen JR, Ribas CR et al (2013) Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase. Chem Biol 20:379–390. https://doi.org/10.1016/j.chembiol.2013.01.012
Della Pietra A, Giniatullin R, Savinainen JR (2021) Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. Int J Mol Sci 22:1204. https://doi.org/10.3390/ijms22031204
Messlinger K, Russo AF (2019) Current understanding of trigeminal ganglion structure and function in headache. Cephalalgia 39:1661–1674. https://doi.org/10.1177/0333102418786261
Schueler M, Neuhuber WL, De Col R, Messlinger K (2014) Innervation of Rat and Human Dura Mater and Pericranial Tissues in the Parieto-Temporal Region by Meningeal Afferents. Headache J Head Face Pain 54:996–1009. https://doi.org/10.1111/head.12371
Fontaine D, Almairac F, Santucci S et al (2018) Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies. Brain 141:1040–1048. https://doi.org/10.1093/brain/awy005
Eren-Koçak E, Dalkara T (2021) Ion Channel Dysfunction and Neuroinflammation in Migraine and Depression . Front Pharmacol 12:777607. https://doi.org/10.3389/fphar.2021.777607
Zhao J, Levy D (2018) The CGRP receptor antagonist BIBN4096 inhibits prolonged meningeal afferent activation evoked by brief local K+ stimulation but not cortical spreading depression-induced afferent sensitization. PAIN Reports 3:e632. https://doi.org/10.1097/PR9.0000000000000632
Levy D, Labastida-Ramirez A, MaassenVanDenBrink A (2019) Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia 39:1606–1622. https://doi.org/10.1177/0333102418771350
Navia-Paldanius D, Patel JZ, López Navarro M et al (2016) Chemoproteomic, biochemical and pharmacological approaches in the discovery of inhibitors targeting human α/β-hydrolase domain containing 11 (ABHD11). Eur J Pharm Sci 93:253–263. https://doi.org/10.1016/j.ejps.2016.08.031
Navia-Paldanius D, Savinainen JR, Laitinen JT (2012) Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12). J Lipid Res 53:2413–2424. https://doi.org/10.1194/jlr.M030411
Lehtonen M, Storvik M, Malinen H et al (2011) Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry. J Chromatogr B 879:677–694. https://doi.org/10.1016/j.jchromb.2011.02.004
Zakharov A, Vitale C, Kilinc E et al (2015) Hunting for origins of migraine pain : cluster analysis of spontaneous and capsaicin-induced firing in meningeal trigeminal nerve fibers. Front Cell Neurosci 9:1–14. https://doi.org/10.3389/fncel.2015.00287
De Col R, Messlinger K, Carr RW (2012) Repetitive activity slows axonal conduction velocity and concomitantly increases mechanical activation threshold in single axons of the rat cranial dura. J Physiol 590:725–736. https://doi.org/10.1113/jphysiol.2011.220624
Gafurov O, Zakharov A, Koroleva K, Giniatullin R (2017) Improvement of Nociceptive Spike Clusterization with Shape Approximation. Bionanoscience 7:565–569. https://doi.org/10.1007/s12668-017-0428-9
Zakharov A, Koroleva K, Giniatullin R (2016) Clustering Analysis for Sorting ATP-Induced Nociceptive Firing in rat Meninges. Bionanoscience 6:508–512. https://doi.org/10.1007/s12668-016-0276-z
Kadir SN, Goodman DFM, Harris KD (2014) High-Dimensional Cluster Analysis with the Masked EM Algorithm. Neural Comput 26:2379–2394. https://doi.org/10.1162/NECO_a_00661
Savinainen JR, Saario SM, Laitinen JT (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol 204:267–276. https://doi.org/10.1111/j.1748-1716.2011.02280.x
Cruz SL, Sánchez-Miranda E, Castillo-Arellano JI et al (2018) Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers. Int Immunopharmacol 64:298–307. https://doi.org/10.1016/j.intimp.2018.09.006
Lutz B, Marsicano G, Maldonado R, Hillard CJ (2015) The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci 16:705–718. https://doi.org/10.1038/nrn4036
Cabral GA, Marciano-Cabral F (2005) Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol 78:1192–1197
Ghosh S, Kinsey SG, Liu Q-S et al (2015) Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. J Pharmacol Exp Ther 354:111–120. https://doi.org/10.1124/jpet.115.222851
Kilinc E, Ankarali S, Torun IE, Dagistan Y (2022) Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine. Eur J Neurosci 55:1015–1031. https://doi.org/10.1111/ejn.14897
Koroleva K, Gafurov O, Guselnikova V, et al (2019) Meningeal Mast Cells Contribute to ATP-Induced Nociceptive Firing in Trigeminal Nerve Terminals: Direct and Indirect Purinergic Mechanisms Triggering Migraine Pain. Front Cell Neurosci 13:. https://doi.org/10.3389/fncel.2019.00195
Greco R, Demartini C, Zanaboni A, et al (2021) Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Neurobiol Dis 147:105157. https://doi.org/10.1016/j.nbd.2020.105157
Greco R, Bandiera T, Mangione A, et al (2015) Effects of peripheral FAAH blockade on NTG-induced hyperalgesia—evaluation of URB937 in an animal model of migraine. Cephalalgia 35:1065–1076. https://doi.org/10.1177/0333102414566862
Chang L, Luo L, Palmer JA et al (2006) Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Br J Pharmacol 148:102–113. https://doi.org/10.1038/sj.bjp.0706699
Della Pietra A, Savinainen J, Giniatullin R (2022) Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. Int J Mol Sci 23:4407. https://doi.org/10.3390/ijms23084407
Piomelli D, Tagne AM (2022) Endocannabinoid-Based Therapies. Annu Rev Pharmacol Toxicol 62:. https://doi.org/10.1146/annurev-pharmtox-052220-021800
Adamson Barnes NS, Mitchell VA, Kazantzis NP, Vaughan CW (2016) Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model. Br J Pharmacol 173:77–87. https://doi.org/10.1111/bph.13337
Greco R, Demartini C, Francavilla M et al (2021) Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. Cells 10:2543. https://doi.org/10.3390/cells10102543
Papa A, Pasquini S, Contri C et al (2022) Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition. Cells 11:471. https://doi.org/10.3390/cells11030471
Long JZ, Nomura DK, Vann RE et al (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci 106:20270–20275. https://doi.org/10.1073/pnas.0909411106
Fischer MJM, Reeh PW (2007) Sensitization to heat through G-protein-coupled receptor pathways in the isolated sciatic mouse nerve. Eur J Neurosci 25:3570–3575. https://doi.org/10.1111/j.1460-9568.2007.05582.x
Bernardini N, Neuhuber W, Reeh P, Sauer S (2004) Morphological evidence for functional capsaicin receptor expression and calcitonin gene-related peptide exocytosis in isolated peripheral nerve axons of the mouse. Neuroscience 126:585–590. https://doi.org/10.1016/j.neuroscience.2004.03.017
Gafurov O, Koroleva K, Giniatullin R (2021) Antidromic Spike Propagation and Dissimilar Expression of P2X, 5-HT, and TRPV1 Channels in Peripheral vs. Central Sensory Axons in Meninges. Front Cell Neurosci 14:. https://doi.org/10.3389/fncel.2020.623134
Edvinsson JCA, Warfvinge K, Krause DN et al (2019) C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. J Headache Pain 20:105. https://doi.org/10.1186/s10194-019-1055-3
Iversen L (2002) Cannabinoids: a real prospect for pain relief. Curr Opin Pharmacol 2:50–55. https://doi.org/10.1016/S1471-4892(01)00120-5
Pertwee RG (2006) The pharmacology of cannabinoid receptors and their ligands: An overview. Int J Obes 30:S13–S18. https://doi.org/10.1038/sj.ijo.0803272
Dux M, Deák É, Tassi N et al (2016) Endovanilloids are potential activators of the trigeminovascular nocisensor complex. J Headache Pain 17:53. https://doi.org/10.1186/s10194-016-0644-7
Akerman S, Kaube H, Goadsby PJ (2004) Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception. J Pharmacol Exp Ther 309:56–63. https://doi.org/10.1124/jpet.103.059808
Muller C, Lynch DL, Hurst DP, Reggio PH (2020) A Closer Look at Anandamide Interaction With TRPV1. Front Mol Biosci 7:. https://doi.org/10.3389/fmolb.2020.00144